SAN JOSE, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) — Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology’s website at http://investor.aligntech.com. An archived replay will remain on the website for approximately three months.
| Conference: | 32nd Annual Piper Sandler Virtual Healthcare Conference |
| Date: | Tuesday, December 1, 2020 |
| Presentation: | 1:30 – 1:55 PM – Eastern Time |
| Location: | Virtual Meeting |
| Speakers: | John Morici, CFO |
| Madelyn Homick, Senior Mgr, Investor Relations and Corporate Communication | |
| Conference: | 3rd Annual Evercore Virtual ISI HealthCONx Conference |
| Date: | Wednesday, December 2, 2020 |
| Presentation: | 1:00 – 1:45 PM – Eastern Time |
| Location: | Virtual Meeting |
| Speakers: | John Morici, CFO |
| Madelyn Homick, Senior Mgr, Investor Relations and Corporate Communication |
About Align Technology, Inc.
Align Technology designs and manufactures the Invisalign® system, the most advanced clear aligner system in the world, iTero® intraoral scanners and services, and CAD/CAM software. Align has helped treat over 9 million patients with the Invisalign system and is driving the evolution in digital dentistry with the iTero intraoral scanner and exocad CAD/CAM software − modernizing today’s practices by enabling enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies. Visit www.aligntech.com for more information.
For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.
| Investor Relations Contact | Press Contact |
| Madelyn Homick | Shannon Mangum Henderson |
| Align Technology, Inc. | Ethos Communication, Inc. |
| (408) 470-1180 | (678) 261-7803 |
| mhomick@aligntech.com | align@ethoscommunication.com |
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…
Demonstrated meaningful overall anemia responses across all patient subgroups, regardless of baseline transfusion status Anemia response…